BIDENS PILOSA AND PHYTOCHEMICAL COMPOUNDS THEREOF FOR USE IN PREVENTING AND TREATING DIARRHOEA Russian patent published in 2024 - IPC A23K10/30 A23K50/30 A61P1/00 

FIELD: veterinary science.

SUBSTANCE: method for reducing the presence of diarrhoea-related intestinal pathogenic microbiota in an animal in need thereof, wherein said method comprises: administering to an animal in need thereof a composition having activity against the intestinal pathogenic microbiota associated with diarrhoea, substantially consisting of a therapeutically effective amount of the Bidens pilosa extract and the animal feed material, where the intestinal pathogenic microbiota is at least one selected from the group consisting of Brachyspira, porcine epizootic diarrhoea virus (PEDV), infectious gastroenteritis coronavirus (TGEV) and rotavirus (RV). Method of treating diarrhoea-related intestinal pathogenic microbiota in an animal in need thereof, wherein said method comprises administering to an animal in need thereof a composition having activity against intestinal pathogenic microbiota associated with diarrhoea, consisting of a therapeutically effective amount of an extract of Bidens pilosa, where the intestinal pathogenic microbiota is at least one selected from the group consisting of Brachyspira, porcine epizootic diarrhoea virus (PEDV), infectious gastroenteritis coronavirus (TGEV) and rotavirus (RV). Use of the composition for reducing the presence of a diarrhoea-related intestinal pathogen in an animal in need thereof, where the composition having activity against the intestinal pathogenic microbiota associated with diarrhoea essentially consists of a therapeutically effective amount of the Bidens pilosa extract and the animal feed material, and further wherein the intestinal pathogenic microbiota is at least one selected from the group consisting of Brachyspira, porcine epizootic diarrhoea virus (PEDV), infectious gastroenteritis coronavirus (TGEV) and rotavirus (RV). Medicinal agent for treating diarrhoea-related intestinal pathogenic microbiota in an animal in need thereof, where said drug essentially consists of a therapeutically effective amount of Bidens pilosa extract and animal feed material, where the intestinal pathogenic microbiota is at least one selected from the group consisting of Brachyspira, porcine epizootic diarrhoea virus (PEDV), infectious gastroenteritis coronavirus (TGEV) and rotavirus (RV). Method for reducing the presence of diarrhoea-related intestinal pathogenic microbiota and increasing the percentage of carcass weight and bone mass of pigs in an animal in need thereof, where said method involves: administering to an animal in need thereof a composition having activity against intestinal pathogenic microbiota associated with diarrhoea, and in need of an increase in the percentage of carcass weight and bone mass of pigs, wherein composition essentially consists of a therapeutically effective amount of Bidens pilosa extract and animal feed material, where the intestinal pathogenic microbiota is at least one selected from the group consisting of Brachyspira, porcine epizootic diarrhoea virus (PEDV), infectious gastroenteritis coronavirus (TGEV) and rotavirus (RV).

EFFECT: inventions make it possible to reduce or replace abuse or misuse of antimicrobial growth promoters (AGP) in pigs and to facilitate meat production.

21 cl, 8 dwg, 4 tbl, 3 ex